Africa: Covid-19 – Local Researchers Welcome Sputnik V Vaccine Findings
February 4, 2021
Local researchers have welcomed findings for Russia’s Sputnik V viral vector vaccine, which achieved efficacy of 91.6% in preventing symptomatic COVID-19 in a large Phase 3 clinical trial. They say it is a boost to global efforts to control the pandemic. The findings from a preliminary analysis of the Phase 3 clinical trial were published